• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Ultragenyx

An artists impression of DNA The DNA appears to be made up of glowing orbs and appears on a blue background
Pharma

Ultragenyx, after FDA speed bump, lands 1st gene therapy nod

The FDA gave an accelerated nod to Ultragenyx’s gene therapy for the rare genetic disorder GSDIa, now christened Genglycos.
Fraiser Kansteiner Aug 19, 2026 10:33pm
Henrietta Lacks

Novartis settles lawsuit with estate of Henrietta Lacks

Feb 24, 2026 10:20am
FDA
Favicon Fierce Biotech

FDA plans real-time release of drug rejection letters

Sep 4, 2025 1:45pm
FDA stop sign

FDA snubs Ultragenyx gene therapy over manufacturing issues

Jul 14, 2025 10:16am
Henrietta Lacks

Novartis, Viatris now face litigation over use of HeLa cells

Aug 6, 2024 8:06am
A doctor holds a gavel

Henrietta Lacks' estate sues Ultragenyx over gene therapy vector

Aug 11, 2023 9:35am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings